Emkay Global Financial Services has maintained its BUY call on Vedanta Limited, adjusting the target price downward to Rs 525 from Rs 550, reflecting a 25% potenti
In its latest report, Emkay Global Financial Services has maintained a ‘Reduce’ rating on Wipro Ltd., citing a soft Q4 performance and underwhelming guidance for Q1 FY26.
Sun Pharmaceutical Industries has received a favorable legal ruling in the United States that clears a key hurdle in launching Leqselvi, its much-anticipated treatment for alopecia areata.
Emkay Research has reaffirmed its BUY rating on Pricol, driven by its recent acquisition of the plastic injection molding business of Sundaram Auto Components (SAC).